{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:39:44Z","timestamp":1759941584041},"reference-count":50,"publisher":"Pharmaceutical Society of Japan","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1248\/bpb.b18-00315","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T22:21:15Z","timestamp":1543616475000},"page":"1769-1777","source":"Crossref","is-referenced-by-count":5,"title":["Novel Strategy for the Systemic Delivery of Furosemide Based on a New Drug Transport Mechanism"],"prefix":"10.1248","volume":"41","author":[{"given":"Shunsuke","family":"Kimura","sequence":"first","affiliation":[{"name":"Department of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Doshisha Women\u2019s College of Liberal Arts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Kiriyama","sequence":"additional","affiliation":[{"name":"Department of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Doshisha Women\u2019s College of Liberal Arts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Doshisha Women\u2019s College of Liberal Arts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiori","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Doshisha Women\u2019s College of Liberal Arts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Inoue","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shujitsu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Furubayashi","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shujitsu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Yutani","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Kobe Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Kobe Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Kusamori","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutics, Kyoto Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemasa","family":"Katsumi","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutics, Kyoto Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Iga","sequence":"additional","affiliation":[{"name":"Department of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Doshisha Women\u2019s College of Liberal Arts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutics, Kyoto Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyasu","family":"Sakane","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Kobe Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Wenlock MC, Austin RP, Barton P, Davis AM, Leeson PD. A comparison of physiochemical property profiles of development and marketed oral drugs. <i>J. Med. Chem.<\/i>, <b>46<\/b>, 1250\u20131256 (2003).","DOI":"10.1021\/jm021053p"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Stegemann S, Leveiller F, Franchi D, De Jong H, Linden H. When poor solubility becomes an issue: from early stage to proof of concept. <i>Eur. J. Pharm. Sci.<\/i>, <b>31<\/b>, 249\u2013261 (2007).","DOI":"10.1016\/j.ejps.2007.05.110"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. <i>Adv. Drug Deliv. Rev.<\/i>, <b>46<\/b>, 3\u201326 (2001).","DOI":"10.1016\/S0169-409X(00)00129-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Shah DA, Murdande SB, Dave RH. A review: Pharmaceutical and pharmacokinetic aspect of nanocrystalline suspensions. <i>J. Pharm. Sci.<\/i>, <b>105<\/b>, 10\u201324 (2016).","DOI":"10.1002\/jps.24694"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Wanning S, Suverkrup R, Lamprecht A. Pharmaceutical spray freeze drying. <i>Int. J. Pharm.<\/i>, <b>488<\/b>, 136\u2013153 (2015).","DOI":"10.1016\/j.ijpharm.2015.04.053"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Fong SY, Brandl M, Bauer-Brandl A. Phospholipid-based solid drug formulations for oral bioavailability enhancement: A meta-analysis. <i>Eur. J. Pharm. Sci.<\/i>, <b>80<\/b>, 89\u2013110 (2015).","DOI":"10.1016\/j.ejps.2015.08.005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Frank KJ, Rosenblatt KM, Westedt U, Holig P, Rosenberg J, Magerlein M, Fricker G, Brandl M. Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: true supersaturation <i>vs.<\/i> apparent solubility enhancement. <i>Int. J. Pharm.<\/i>, <b>437<\/b>, 288\u2013293 (2012).","DOI":"10.1016\/j.ijpharm.2012.08.014"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ueda K, Higashi K, Limwikrant W, Sekine S, Horie T, Yamamoto K, Moribe K. Mechanistic differences in permeation behavior of supersaturated and solubilized solutions of carbamazepine revealed by nuclear magnetic resonance measurements. <i>Mol. Pharm.<\/i>, <b>9<\/b>, 3023\u20133033 (2012).","DOI":"10.1021\/mp300083e"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kimura S, Kasatani S, Tanaka M, Araki K, Enomura M, Moriyama K, Inoue D, Furubayashi T, Tanaka A, Kusamori K, Katsumi H, Sakane T, Yamamoto A. Importance of the direct contact of amorphous solid particles with the surface of monolayers for the transepithelial permeation of curcumin. <i>Mol. Pharm.<\/i>, <b>13<\/b>, 493\u2013499 (2016).","DOI":"10.1021\/acs.molpharmaceut.5b00710"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Miller JM, Beig A, Krieg BJ, Carr RA, Borchardt TB, Amidon GE, Amidon GL, Dahan A. The solubility-permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation. <i>Mol. Pharm.<\/i>, <b>8<\/b>, 1848\u20131856 (2011).","DOI":"10.1021\/mp200181v"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Poelma FG, Breas R, Tukker JJ. Intestinal absorption of drugs. III. The influence of taurocholate on the disappearance kinetics of hydrophilic and lipophilic drugs from the small intestine of the rat. <i>Pharm. Res.<\/i>, <b>7<\/b>, 392\u2013397 (1990).","DOI":"10.1023\/A:1015827624296"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kimura S, Kiriyama A, Araki K, Yoshizumi M, Enomura M, Inoue D, Furubayashi T, Yutani R, Teraoka R, Tanaka A, Kusamori K, Katsumi H, Yamamoto A, Iga K, Sakane T. Novel strategy for improving the bioavailability of curcumin based on a new membrane transport mechanism that directly involves solid particles. <i>Eur. J. Pharm. Biopharm.<\/i>, <b>122<\/b>, 1\u20135 (2018).","DOI":"10.1016\/j.ejpb.2017.09.017"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Wang Y, Wang C, Zhao J, Ding Y, Li L. A cost-effective method to prepare curcumin nanosuspensions with enhanced oral bioavailability. <i>J. Colloid Interface Sci.<\/i>, <b>485<\/b>, 91\u201398 (2017).","DOI":"10.1016\/j.jcis.2016.09.003"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Anwar M, Ahmad I, Warsi MH, Mohapatra S, Ahmad N, Akhter S, Ali A, Ahmad FJ. Experimental investigation and oral bioavailability enhancement of nano-sized curcumin by using supercritical anti-solvent process. <i>Eur. J. Pharm. Biopharm.<\/i>, <b>96<\/b>, 162\u2013172 (2015).","DOI":"10.1016\/j.ejpb.2015.07.021"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Sadeghi F, Ashofteh M, Homayouni A, Abbaspour M, Nokhodchi A, Garekani HA. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement. <i>Colloids Surf. B Biointerfaces<\/i>, <b>147<\/b>, 258\u2013264 (2016).","DOI":"10.1016\/j.colsurfb.2016.08.004"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Paradkar A, Ambike AA, Jadhav BK, Mahadik KR. Characterization of curcumin-PVP solid dispersion obtained by spray drying. <i>Int. J. Pharm.<\/i>, <b>271<\/b>, 281\u2013286 (2004).","DOI":"10.1016\/j.ijpharm.2003.11.014"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Onoue S, Takahashi H, Kawabata Y, Seto Y, Hatanaka J, Timmermann B, Yamada S. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. <i>J. Pharm. Sci.<\/i>, <b>99<\/b>, 1871\u20131881 (2010).","DOI":"10.1002\/jps.21964"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) T\u00f8nnesen HH, Masson M, Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. <i>Int. J. Pharm.<\/i>, <b>244<\/b>, 127\u2013135 (2002).","DOI":"10.1016\/S0378-5173(02)00323-X"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kaminaga Y, Nagatsu A, Akiyama T, Sugimoto N, Yamazaki T, Maitani T, Mizukami H. Production of unnatural glucosides of curcumin with drastically enhanced water solubility by cell suspension cultures of Catharanthus roseus. <i>FEBS Lett.<\/i>, <b>555<\/b>, 311\u2013316 (2003).","DOI":"10.1016\/S0014-5793(03)01265-1"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Fasinu P, Pillay V, Ndesendo VM, du Toit LC, Choonara YE. Diverse approaches for the enhancement of oral drug bioavailability. <i>Biopharm. Drug Dispos.<\/i>, <b>32<\/b>, 185\u2013209 (2011).","DOI":"10.1002\/bdd.750"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Nkansah P, Antipas A, Lu Y, Varma M, Rotter C, Rago B, El-Kattan A, Taylor G, Rubio M, Litchfield J. Development and evaluation of novel solid nanodispersion system for oral delivery of poorly water-soluble drugs. <i>J. Control. Release<\/i>, <b>169<\/b>, 150\u2013161 (2013).","DOI":"10.1016\/j.jconrel.2013.03.032"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Rabbie SC, Flanagan T, Martin PD, Basit AW. Inter-subject variability in intestinal drug solubility. <i>Int. J. Pharm.<\/i>, <b>485<\/b>, 229\u2013234 (2015).","DOI":"10.1016\/j.ijpharm.2015.03.006"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Corti G, Maestrelli F, Cirri M, Zerrouk N, Mura P. Development and evaluation of an <i>in vitro<\/i> method for prediction of human drug absorption: II. Demonstration of the method suitability. <i>Eur. J. Pharm. Sci.<\/i>, <b>27<\/b>, 354\u2013362 (2006).","DOI":"10.1016\/j.ejps.2005.11.005"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Yamashita S, Furubayashi T, Kataoka M, Sakane T, Sezaki H, Tokuda H. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. <i>Eur. J. Pharm. Sci.<\/i>, <b>10<\/b>, 195\u2013204 (2000).","DOI":"10.1016\/S0928-0987(00)00076-2"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Granero GE, Longhi MR, Mora MJ, Junginger HE, Midha KK, Shah VP, Stavchansky S, Dressman JB, Barends DM. Biowaiver monographs for immediate release solid oral dosage forms: furosemide. <i>J. Pharm. Sci.<\/i>, <b>99<\/b>, 2544\u20132556 (2010).","DOI":"10.1002\/jps.22030"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Radwan SE, Sokar MS, Abdelmonsif DA, El-Kamel AH. Mucopenetrating nanoparticles for enhancement of oral bioavailability of furosemide: <i>In vitro<\/i> and <i>in vivo<\/i> evaluation\/sub-acute toxicity study. <i>Int. J. Pharm.<\/i>, <b>526<\/b>, 366\u2013379 (2017).","DOI":"10.1016\/j.ijpharm.2017.04.072"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Chen L, Okuda T, Lu XY, Chan HK. Amorphous powders for inhalation drug delivery. <i>Adv. Drug Deliv. Rev.<\/i>, <b>100<\/b>, 102\u2013115 (2016).","DOI":"10.1016\/j.addr.2016.01.002"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Patton JS. Mechanisms of macromolecule absorption by the lungs. <i>Adv. Drug Deliv. Rev.<\/i>, <b>19<\/b>, 3\u201336 (1996).","DOI":"10.1016\/0169-409X(95)00113-L"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Amancha KP, Hussain A. Effect of protease inhibitors on pulmonary bioavailability of therapeutic proteins and peptides in the rat. <i>Eur. J. Pharm. Sci.<\/i>, <b>68<\/b>, 1\u201310 (2015).","DOI":"10.1016\/j.ejps.2014.11.008"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Hussain A, Majumder QH, Ahsan F. Inhaled insulin is better absorbed when administered as a dry powder compared to solution in the presence or absence of alkylglycosides. <i>Pharm. Res.<\/i>, <b>23<\/b>, 138\u2013147 (2006).","DOI":"10.1007\/s11095-005-8926-9"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Santos Cavaiola T, Edelman S. Inhaled insulin: a breath of fresh air? A review of inhaled insulin. <i>Clin. Ther.<\/i>, <b>36<\/b>, 1275\u20131289 (2014).","DOI":"10.1016\/j.clinthera.2014.06.025"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Jensen KT, Larsen FH, Cornett C, Lobmann K, Grohganz H, Rades T. Formation mechanism of coamorphous drug\u2013amino acid mixtures. <i>Mol. Pharm.<\/i>, <b>12<\/b>, 2484\u20132492 (2015).","DOI":"10.1021\/acs.molpharmaceut.5b00295"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Avdeef A, Strafford M, Block E, Balogh MP, Chambliss W, Khan I. Drug absorption <i>in vitro<\/i> model: filter-immobilized artificial membranes: 2. Studies of the permeability properties of lactones in <i>Piper methysticum<\/i> Forst. <i>Eur. J. Pharm. Sci.<\/i>, <b>14<\/b>, 271\u2013280 (2001).","DOI":"10.1016\/S0928-0987(01)00191-9"},{"key":"34","unstructured":"34) Derakhshandeh K, Karimi M, Azandaryani AH, Bahrami G, Ghanbari K. Pharmacokinetic study of furosemide incorporated PLGA microspheres after oral administration to rat. <i>Iran. J. Basic Med. Sci.<\/i>, <b>19<\/b>, 1049\u20131055 (2016)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Matsuda Y, Tatsumi E. Physicochemical characterization of furosemide modifications. <i>Int. J. Pharm.<\/i>, <b>60<\/b>, 11\u201326 (1990).","DOI":"10.1016\/0378-5173(90)90185-7"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Fioritto AF, Bhattachar SN, Wesley JA. Solubility measurement of polymorphic compounds <i>via<\/i> the pH-metric titration technique. <i>Int. J. Pharm.<\/i>, <b>330<\/b>, 105\u2013113 (2007).","DOI":"10.1016\/j.ijpharm.2006.09.003"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Pade V, Stavchansky S. Link between drug absorption solubility and permeability measurements in Caco-2 cells. <i>J. Pharm. Sci.<\/i>, <b>87<\/b>, 1604\u20131607 (1998).","DOI":"10.1021\/js980111k"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Zvonar A, Berginc K, Kristl A, Gasperlin M. Microencapsulation of self-microemulsifying system: improving solubility and permeability of furosemide. <i>Int. J. Pharm.<\/i>, <b>388<\/b>, 151\u2013158 (2010).","DOI":"10.1016\/j.ijpharm.2009.12.055"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Kaukonen AM, Laitinen L, Salonen J, Tuura J, Heikkila T, Limnell T, Hirvonen J, Lehto VP. Enhanced <i>in vitro<\/i> permeation of furosemide loaded into thermally carbonized mesoporous silicon (TCPSi) microparticles. <i>Eur. J. Pharm. Biopharm.<\/i>, <b>66<\/b>, 348\u2013356 (2007).","DOI":"10.1016\/j.ejpb.2006.11.021"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Rege BD, Yu LX, Hussain AS, Polli JE. Effect of common excipients on Caco-2 transport of low-permeability drugs. <i>J. Pharm. Sci.<\/i>, <b>90<\/b>, 1776\u20131786 (2001).","DOI":"10.1002\/jps.1127"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Fujikawa M, Ano R, Nakao K, Shimizu R, Akamatsu M. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability. <i>Bioorg. Med. Chem.<\/i>, <b>13<\/b>, 4721\u20134732 (2005).","DOI":"10.1016\/j.bmc.2005.04.076"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Avdeef A, Artursson P, Neuhoff S, Lazorova L, Grasjo J, Tavelin S. Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA p<i>K<\/i>a(flux) method. <i>Eur. J. Pharm. Sci.<\/i>, <b>24<\/b>, 333\u2013349 (2005).","DOI":"10.1016\/j.ejps.2004.11.011"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Kansy M, Senner F, Gubernator K. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. <i>J. Med. Chem.<\/i>, <b>41<\/b>, 1007\u20131010 (1998).","DOI":"10.1021\/jm970530e"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Zhu C, Jiang L, Chen TM, Hwang KK. A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential. <i>Eur. J. Med. Chem.<\/i>, <b>37<\/b>, 399\u2013407 (2002).","DOI":"10.1016\/S0223-5234(02)01360-0"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Asai A, Okuda T, Sonoda E, Yamauchi T, Kato S, Okamoto H. Drug permeation characterization of inhaled dry powder formulations in air\u2013liquid interfaced cell layer using an improved, simple apparatus for dispersion. <i>Pharm. Res.<\/i>, <b>33<\/b>, 487\u2013497 (2016).","DOI":"10.1007\/s11095-015-1804-1"},{"key":"46","unstructured":"46) De Backer L, Cerrada A, Perez-Gil J, De Smedt SC, Raemdonck K. Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy. <i>J. Control. Release<\/i>, <b>220<\/b> (Pt B), 642\u2013650 (2015)."},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Hidalgo A, Cruz A, Perez-Gil J. Barrier or carrier? Pulmonary surfactant and drug delivery. <i>Eur. J. Pharm. Biopharm.<\/i>, <b>95<\/b> (Pt A), 117\u2013127 (2015).","DOI":"10.1016\/j.ejpb.2015.02.014"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Weers JG, Miller DP. Formulation design of dry powders for inhalation. <i>J. Pharm. Sci.<\/i>, <b>104<\/b>, 3259\u20133288 (2015).","DOI":"10.1002\/jps.24574"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Kawashima Y, Yamamoto H, Takeuchi H, Fujioka S, Hino T. Pulmonary delivery of insulin with nebulized DL-lactide\/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. <i>J. Control. Release<\/i>, <b>62<\/b>, 279\u2013287 (1999).","DOI":"10.1016\/S0168-3659(99)00048-6"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Kaminskas LM, McLeod VM, Ryan GM, Kelly BD, Haynes JM, Williamson M, Thienthong N, Owen DJ, Porter CJ. Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy. <i>J. Control. Release<\/i>, <b>183<\/b>, 18\u201326 (2014).","DOI":"10.1016\/j.jconrel.2014.03.012"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/12\/41_b18-00315\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T12:34:37Z","timestamp":1573043677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/12\/41_b18-00315\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b18-00315","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,1]]}}}